DV Trading’s Pfizer PFE Stock Holding History

DV Trading’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,700	Closed	-$329K	–	657
2026 Q1	$329K	Buy	+11,700	New	+$311K	0.01%	270

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DV Trading's PFE Position: Q2 2026 in Review

DV Trading increased its Pfizer (PFE) stake by 50% in Q2 2026, buying an estimated $252K and bringing the position to 28,867 shares worth $695K. The position accounts for 0.02% of the portfolio, ranked #185.

DV Trading first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

DV Trading held 28,867 shares of Pfizer worth $695K as of Q2 2026.
DV Trading bought 9,627 Pfizer shares in Q2 2026, an estimated $252K.
Pfizer made up 0.02% of DV Trading's portfolio in Q2 2026, its #185 holding.
DV Trading first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on DV Trading's 13F filing for Q2 2026, filed 14 Aug 2026.